BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 30312628)

  • 1. Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes.
    Adamska A; Araszkiewicz A; Pilacinski S; Gandecka A; Grzelka A; Kowalska K; Malinska A; Nowicki M; Zozulinska-Ziolkiewicz D
    Microvasc Res; 2019 Jan; 121():46-51. PubMed ID: 30312628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between sudomotor function and skin microvascular reactivity in individuals with type 1 diabetes of long duration.
    Gandecka A; Araszkiewicz A; Piłaciński S; Wierusz-Wysocka B; Zozulińska-Ziółkiewicz D
    Microvasc Res; 2018 Nov; 120():84-89. PubMed ID: 30044961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An increased skin microvessel density is associated with neurovascular complications in type 1 diabetes mellitus.
    Adamska A; Pilacinski S; Zozulinska-Ziolkiewicz D; Gandecka A; Grzelka A; Konwerska A; Malinska A; Nowicki M; Araszkiewicz A
    Diab Vasc Dis Res; 2019 Nov; 16(6):513-522. PubMed ID: 31144511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin microvascular function in patients with type 1 diabetes: An observational study from the onset of diabetes.
    Santesson P; Lins PE; Kalani M; Adamson U; Lelic I; von Wendt G; Fagrell B; Jörneskog G
    Diab Vasc Dis Res; 2017 May; 14(3):191-199. PubMed ID: 28467200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes.
    Ninomiya H; Katakami N; Sato I; Osawa S; Yamamoto Y; Takahara M; Kawamori D; Matsuoka TA; Shimomura I
    J Atheroscler Thromb; 2018 Dec; 25(12):1274-1284. PubMed ID: 29962379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus.
    Genevieve M; Vivot A; Gonzalez C; Raffaitin C; Barberger-Gateau P; Gin H; Rigalleau V
    Diabetes Metab; 2013 Sep; 39(4):349-54. PubMed ID: 23643347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Self-reported Physical Activity and Skin Autofluorescence, a Marker of Tissue Accumulation of Advanced Glycation End Products in Adults With Type 1 Diabetes: A Cross-sectional Study.
    Duda-Sobczak A; Falkowski B; Araszkiewicz A; Zozulinska-Ziolkiewicz D
    Clin Ther; 2018 Jun; 40(6):872-880. PubMed ID: 29567299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin Autofluorescence is Associated with Early-stage Atherosclerosis in Patients with Type 1 Diabetes.
    Osawa S; Katakami N; Kuroda A; Takahara M; Sakamoto F; Kawamori D; Matsuoka T; Matsuhisa M; Shimomura I
    J Atheroscler Thromb; 2017 Mar; 24(3):312-326. PubMed ID: 27592627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.
    Genuth S; Sun W; Cleary P; Gao X; Sell DR; Lachin J; ; Monnier VM
    Diabetes; 2015 Jan; 64(1):266-78. PubMed ID: 25187362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic microangiopathy: Pathogenetic insights and novel therapeutic approaches.
    Madonna R; Balistreri CR; Geng YJ; De Caterina R
    Vascul Pharmacol; 2017 Mar; 90():1-7. PubMed ID: 28137665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In diabetic Charcot neuroarthropathy impaired microvascular function is related to long lasting metabolic control and low grade inflammatory process.
    Araszkiewicz A; Soska J; Borucka K; Olszewska M; Niedzwiecki P; Wierusz-Wysocka B; Zozulinska-Ziolkiewicz D
    Microvasc Res; 2015 Sep; 101():143-7. PubMed ID: 26239695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes.
    Osawa S; Katakami N; Sato I; Ninomiya H; Omori K; Yamamoto Y; Takahara M; Miyashita K; Sakamoto F; Kawamori D; Matsuoka T; Shimomura I
    J Diabetes Complications; 2018 Sep; 32(9):839-844. PubMed ID: 30099985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction.
    Januszewski AS; Sachithanandan N; Karschimkus C; O'Neal DN; Yeung CK; Alkatib N; Jenkins AJ
    Diabet Med; 2012 Jun; 29(6):726-33. PubMed ID: 22211881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes.
    Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Nakayama M; Miyata T; Watanabe T
    Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin autofluorescence is associated with carotid intima-media thickness, diabetic microangiopathy, and long-lasting metabolic control in type 1 diabetic patients. Results from Poznan Prospective Study.
    Araszkiewicz A; Naskret D; Zozulinska-Ziolkiewicz D; Pilacinski S; Uruska A; Grzelka A; Wegner M; Wierusz-Wysocka B
    Microvasc Res; 2015 Mar; 98():62-7. PubMed ID: 25582078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of advanced glycation end products in the skin is accelerated in relation to insulin resistance in people with Type 1 diabetes mellitus.
    Uruska A; Gandecka A; Araszkiewicz A; Zozulinska-Ziolkiewicz D
    Diabet Med; 2019 May; 36(5):620-625. PubMed ID: 30706538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes.
    Sell DR; Sun W; Gao X; Strauch C; Lachin JM; Cleary PA; Genuth S; ; Monnier VM
    Cardiovasc Diabetol; 2016 Feb; 15():30. PubMed ID: 26864236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensibility and specificity of laser speckle contrast imaging according to Endo-PAT index in type 1 diabetes.
    Matheus ASM; da Matta MFB; Clemente ELS; Rodrigues MLG; Valença DCT; Gomes MB
    Microvasc Res; 2018 May; 117():10-15. PubMed ID: 29203235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes.
    Genuth S; Sun W; Cleary P; Sell DR; Dahms W; Malone J; Sivitz W; Monnier VM;
    Diabetes; 2005 Nov; 54(11):3103-11. PubMed ID: 16249432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.
    Blanc-Bisson C; Velayoudom-Cephise FL; Cougnard-Gregoire A; Helmer C; Rajaobelina K; Delcourt C; Alexandre L; Blanco L; Mohammedi K; Monlun M; Rigalleau V
    Cardiovasc Diabetol; 2018 Jun; 17(1):82. PubMed ID: 29884175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.